1. Your details Please provide accurate information so the clinician can identify you and assess treatment safely.
Full name (Required)
First
Last
2. Treatment or clinical service requested Choose your main treatment or clinical service. Only the relevant questions and procedure information will be shown. If more than one procedure is planned, tell the practitioner so each can be assessed and consented for appropriately.
Which treatment or clinical service are you attending for? (Required) Select your treatment or clinical service Botulinum toxin / anti-wrinkle treatment Dermal filler Lip augmentation (dermal filler) Skin booster / biorevitalisation injection Platelet-rich plasma (PRP) Conventional microneedling Radiofrequency (RF) microneedling Chemical peel High-intensity focused ultrasound (HIFU) Fractional CO2 laser Thulium laser Sclerotherapy / microsclerotherapy Hyaluronidase / dermal filler dissolving Assessment / management of an aesthetic complication Ear irrigation Blood test / venepuncture Suture removal Skin clip / staple removal
Age confirmation (Required) I confirm that I am aged 18 years or over. For cosmetic botulinum toxin and filler procedures in England, the clinic may require acceptable proof of age before treatment. This declaration does not replace the clinic's ID-checking process.
I confirm that I am aged 18 or over
What would you like the treatment to improve or achieve? (Required) Please describe your own goals in your own words. Results cannot be guaranteed.
Is this treatment entirely your own decision? (Required) Cosmetic treatment should be voluntary.
Please tell us about any pressure or concerns (Required) The practitioner will discuss this privately with you before deciding whether treatment is appropriate.
3. Medical screening for aesthetic treatments Please answer every question. A 'Yes' answer does not automatically mean you cannot be treated; it means the practitioner needs to review it.
Do you have any allergies or have you ever had a severe allergic reaction / anaphylaxis? (Required) Do you take any prescribed medicines, over-the-counter medicines, supplements, anticoagulants / blood thinners, steroids, immune-suppressing medicines, retinoids or photosensitising medicines? (Required) Are you pregnant, breastfeeding, or currently trying to become pregnant? (Required) Are you currently unwell, taking antibiotics, or do you have an active infection? (Required) Do you have an active rash, dermatitis, acne flare, open wound, inflamed skin, or other skin condition in or near the proposed treatment area? (Required) Do you have a history of cold sores / herpes simplex in or near the treatment area? (Required) Do you have a bleeding or clotting disorder, low platelets, unexplained bruising, or do you take medication that affects bleeding or clotting? (Required) Do you have an autoimmune condition, immune suppression, active cancer treatment, or have you recently had chemotherapy or radiotherapy? (Required) Do you have diabetes, poor circulation, or a history of delayed wound healing? (Required) Do you have a history of keloid or hypertrophic scarring? (Required) Do you have a neurological or neuromuscular condition, seizures, swallowing problems, or significant muscle weakness? (Required) Do you have a pacemaker, implanted defibrillator, cochlear implant, metal implant, or other implanted electronic/medical device? (Required) Do you have melasma or another pigment disorder, or have you had a recent suntan, sunburn or sunbed exposure? (Required) Are you taking, or have you recently taken, oral isotretinoin or another prescription retinoid? (Required) Have you previously had filler, permanent filler, threads, implants, surgery, laser/energy treatment or another aesthetic procedure in the area to be treated? (Required) Have you ever had an unexpected reaction or complication following an aesthetic, injectable, laser, peel or skin procedure? (Required) Have you ever reacted badly to local anaesthetic, lidocaine, antiseptic, latex or medical adhesive? (Required) Do you smoke or vape nicotine? (Required) Please give details of every 'Yes' answer (Required) Include diagnoses, medicine names and doses where known, dates, previous reactions and anything else the clinician should know.
4. Ear irrigation The clinician must examine the ear(s), review your answers and check the method is appropriate before attempting wax removal. Ear irrigation is not suitable for everyone.
Which ear is being assessed? (Required) Have you used wax-softening drops as advised before this appointment? (Required) The clinician may decide to defer irrigation if the wax has not been adequately softened.
Have you ever had a perforated eardrum, grommet, or been told there is a hole in your eardrum? (Required) Have you ever had surgery on the ear being treated? (Required) Do you currently have, or have you recently had, ear infection, significant ear pain, discharge or bleeding from the ear? (Required) Have you previously had a problem or complication with ear irrigation? (Required) Is the ear being considered for irrigation your only hearing ear? (Required) Have you experienced sudden or rapidly worsening hearing, significant new dizziness/vertigo, or another sudden change in ear symptoms? (Required) Do you have a cochlear implant or another implanted hearing device? (Required) Have you experienced ongoing or recurrent vertigo, severe tinnitus, or any other unusual ear symptoms? (Required) Please explain any relevant ear history or any Yes / Unsure answers If you are not sure about a past ear condition, tell the clinician. Do not guess.
Ear irrigation consent (Required) I understand the purpose of the procedure, what it involves, its material risks and reasonable alternatives, and that wax may not be removed or my symptoms resolved. I understand that the clinician may decide not to proceed, may stop during treatment, or may recommend referral. I have had an opportunity to ask questions; I may refuse or withdraw consent before the procedure, and consenting does not waive my legal rights. Final consent will be confirmed by the clinician before treatment.
I consent to ear irrigation following the clinicianโs assessment, if it is clinically appropriate.
4. Blood test / venepuncture The clinician will identify the requested test(s), check relevant preparation and whether it is appropriate to collect the sample safely.
Have you been told to fast or follow any special preparation instructions for this test? (Required) Have you followed the preparation instructions you were given? (Required) The clinician may need to check whether the sample should be taken today.
Do you have a history of fainting, feeling very dizzy, or significant anxiety around needles or blood tests? (Required) Have you previously been told that taking blood from you is difficult? (Required) Do you have a bleeding disorder, bruise very easily, or take anticoagulant / blood-thinning medication? (Required) Do you have anything that may affect which arm can safely be used, such as previous breast/axillary surgery or lymph-node removal, a dialysis fistula/graft, PICC line or other vascular-access device? (Required) Do you have a known allergy or significant skin reaction to plasters, medical adhesive, latex or skin-cleansing products? (Required) Who requested your blood test(s)? (Required) Do you know which service will receive and review your results? (Required) Please explain any Yes / Unsure answers or relevant blood-test history Include fainting, bleeding, access restrictions, difficult venepuncture or test-preparation concerns.
Blood test / venepuncture consent (Required) I understand why the blood sample is requested, how venepuncture is performed, material risks and alternatives, and that collection can be unsuccessful or may need repeating. I understand that an abnormal result alone does not establish a diagnosis and that the responsible clinician/service must explain the results and any follow-up. I have had the opportunity to ask questions; I may refuse or withdraw consent, and consenting does not waive my legal rights. Final consent will be confirmed before sample collection.
I consent to venepuncture for the requested blood test(s), following clinical checks.
4. Suture or skin clip/staple removal For both sutures and skin clips/staples, the nurse must inspect the wound, establish the closure type and due date, consider infection/healing concerns and record a reasoned decision to proceed, remove some only, defer, stop or refer.
Reason for sutures / clips and original procedure Briefly describe the operation, injury or reason the wound was closed, if known.
What instructions were you given for suture or clip/staple removal? Include the recommended removal date and the hospital, clinic or clinician that gave the instructions if known.
Have you been advised that the sutures or clips/staples are due to be removed now? (Required) Does the wound currently have increasing redness, warmth, swelling, worsening pain, pus/discharge, bleeding, fever, or any opening/gaping of the wound? (Required) Are you currently taking antibiotics for this wound or a related infection? (Required) Do you have a bleeding disorder or take anticoagulant / blood-thinning medication? (Required) Do you have a condition or treatment that may affect wound healing, such as diabetes, immune suppression or regular steroid treatment? (Required) Do you have a known allergy or significant reaction to dressings, Steri-Strips or medical adhesive? (Required) Do you have any other concerns about the wound or any previous complications? (Required) Please describe your wound concerns or previous complications (Required)
Suture removal consent (Required) I understand how my stitches will be assessed and removed, the possibility of pain, minor bleeding, infection becoming apparent, wound separation, delayed healing, scarring or a retained/broken/embedded suture, and the alternatives including deferral or referral. I understand that the nurse may modify, partially complete, stop or decline removal. I have had the opportunity to ask questions; I may refuse or withdraw consent and this does not waive my legal rights. Final consent will be confirmed before the procedure.
I consent to wound assessment and, if appropriate, removal of my sutures/stitches and any routine wound care.
Skin clip / staple removal consent (Required) I understand how skin clips/staples will be assessed and removed, the possible pulling/pinching discomfort, bleeding, inflammation/infection becoming apparent, delayed healing, wound separation/reopening, scarring, and the possibility that a clip is difficult to release or removal must be partial, stopped or deferred. I understand the alternatives including leaving clips in place temporarily or referral to the original treating service. I have had the opportunity to ask questions; I may refuse or withdraw consent and this does not waive my legal rights. Final consent will be confirmed before the procedure.
I consent to wound assessment and, if appropriate, removal of my skin clips/staples and any routine wound care.
4A. Botulinum toxin / anti-wrinkle treatment This section appears because you selected botulinum toxin / anti-wrinkle treatment.
Planned treatment area(s) Final sites, indication and dose must be confirmed by the prescriber/treating practitioner.
Have you had any botulinum toxin treatment within the last 4 months? (Required) Botulinum toxin treatment consent (Required)
What the treatment is: Botulinum toxin is a prescription-only medicine that temporarily reduces signalling between nerves and selected muscles or glands. The exact medicine, indication, dose and injection sites will be chosen after clinical assessment. Some cosmetic uses or treatment sites may be outside the medicine's licensed indication; if so, the prescriber must explain this and why it is being recommended.
Expected result and limitations: The effect is temporary, varies between people and may be incomplete or asymmetrical. More than one treatment or adjustment may be needed. No result can be guaranteed.
Common / important risks: injection discomfort, redness, swelling, bruising, headache, local tenderness, infection, temporary asymmetry, under-correction or over-correction, and unwanted weakness of nearby muscles. Depending on the area treated, effects can include eyebrow or eyelid droop, dry or watering eyes, altered smile or lip movement, chewing weakness, neck weakness, voice change, or difficulty swallowing. Rarely, toxin effects can spread beyond the intended area and cause significant weakness, swallowing, speech or breathing problems. Allergic reactions, including severe reactions, are possible.
Alternatives: no treatment, skin care, other non-injectable procedures, or alternative aesthetic approaches depending on your goals.
Important: This online acknowledgement is not the final consent. Your prescriber/treating practitioner must assess you, discuss the risks most relevant to you, answer your questions and confirm consent before injection.
I have read and understood the botulinum toxin information and wish to proceed to a clinician-led consent discussion
4B. Dermal filler This section appears because you selected dermal filler.
Planned filler area(s) Have you had a recent dental infection/procedure, or do you have dental work planned soon? (Required) Tell the practitioner the date and type of dental work in the medical-details box.
Dermal filler treatment consent (Required)
What the treatment is: Dermal filler is injected to add, restore or reshape volume. The exact product, amount, depth and site must be agreed after assessment. Results and duration vary; asymmetry or further treatment may occur and no result can be guaranteed.
Expected and common effects: pain or stinging, redness, swelling, tenderness, bruising, temporary firmness, visible or palpable product and short-term asymmetry.
Other important risks: infection, cold-sore reactivation, persistent swelling, lumps or nodules, inflammatory or delayed reactions, granuloma, migration, contour irregularity, skin discolouration, Tyndall effect with superficial hyaluronic-acid filler, scarring, and the need for corrective treatment or dissolution where appropriate.
Vascular occlusion: filler can accidentally enter or compress a blood vessel. This is uncommon but can cause severe pain, skin blanching or colour change, tissue damage/necrosis and scarring. In very rare cases, vascular events involving vessels connected to the eye or brain can cause visual loss/blindness or neurological injury including stroke. This requires urgent recognition and treatment; hyaluronidase may be recommended for hyaluronic-acid filler.
Alternatives: no treatment, different filler strategy, skin treatments, energy-based treatments, surgery or other options depending on the clinical problem.
Important: This online acknowledgement is not the final consent. The treating practitioner must discuss the risks most relevant to your anatomy, treatment area and chosen product, answer questions and confirm consent before injection.
I have read and understood the dermal filler information and wish to proceed to a clinician-led consent discussion
4C. Lip augmentation (dermal filler) This section appears because you selected lip augmentation.
Lip treatment goal(s) Lip augmentation consent (Required)
What the treatment is: Lip augmentation generally uses injectable dermal filler to alter volume, definition, proportion or symmetry. The exact product, amount and technique are selected after assessment. Results are temporary and individual; perfect symmetry cannot be guaranteed.
Common / expected effects: swelling (sometimes marked for the first few days), tenderness, bruising, redness, firmness and temporary unevenness. Lumps may occur and may need massage, review, additional treatment or dissolution.
Important risks: infection, cold-sore reactivation, nodules, delayed inflammatory reaction, migration, persistent asymmetry, contour irregularity, scarring and dissatisfaction. As with all dermal filler, accidental vascular occlusion can cause skin injury/necrosis and scarring, and in very rare circumstances visual loss/blindness or neurological injury. Urgent assessment is required if severe pain, blanching, mottled/discoloured skin or visual symptoms occur.
Alternatives: no treatment, non-filler lip treatments, skin care or other approaches depending on your goals.
Important: This acknowledgement does not replace the practitioner's assessment and final consent discussion before injection.
I have read and understood the lip filler information and wish to proceed to a clinician-led consent discussion
4D. Skin booster / biorevitalisation injection This section appears because you selected a skin booster / biorevitalisation treatment.
Which product is planned? (Required) Product formulation and licensed/device status must be checked by the practitioner before use.
Select product Profhilo Sunekos Polynucleotides Lumi Eyes / PDRN-type eye treatment Other / to be confirmed by practitioner
Planned treatment area(s) Do you have a known fish, salmon or trout allergy? (Required) Some polynucleotide/PDRN products may be derived from fish. The practitioner must verify the exact product ingredients and manufacturer contraindications.
Skin booster / biorevitalisation consent (Required)
What the treatment is: Skin boosters / biorevitalisation injections are products placed into or under the skin to improve skin quality, hydration or related aesthetic concerns. Products differ substantially in composition (for example hyaluronic-acid, amino-acid or polynucleotide/PDRN-based formulations), so the exact product, ingredients, treatment protocol and manufacturer instructions must be confirmed before treatment.
Expected / common effects: injection pain, redness, swelling, bruising, tenderness, temporary bumps/papules, itching and short-term unevenness. Under-eye swelling can be more noticeable with periocular treatment.
Other important risks: infection, cold-sore reactivation, persistent swelling, nodules, inflammatory or allergic reactions, granuloma, pigment change, scarring, asymmetry and dissatisfaction. Injectable products can rarely cause vascular compromise; the seriousness and emergency management depend on the product and injection site.
Product-specific risks: allergies and contraindications vary with ingredients and source material. The practitioner must review the selected product's current instructions and explain any additional risks that apply to you.
Alternatives: no treatment, topical skin care, microneedling, PRP, energy-based treatments or other options depending on your goals.
Important: Final suitability and consent must be confirmed with the treating practitioner before injection.
I have read and understood the skin booster information and wish to proceed to a clinician-led consent discussion
4E. Platelet-rich plasma (PRP) This section appears because you selected PRP.
Planned PRP area (Required) Have you been told you have anaemia, low platelets, platelet dysfunction, a blood-borne infection, or another significant blood disorder? (Required) PRP consent (Required)
What the treatment is: PRP uses a sample of your own blood, processed to concentrate platelets/plasma, which is then injected or applied according to the agreed treatment plan. Response varies and more than one session may be recommended. Improvement cannot be guaranteed.
Venepuncture risks: pain, bruising, bleeding, fainting, haematoma and infection at the blood-taking site.
Treatment-area risks: pain, redness, swelling, bruising, tenderness, temporary lumpiness, headache with scalp treatment, temporary worsening or shedding of hair in some scalp patients, infection, inflammation, pigment change and scarring. Because the material is autologous, allergy to PRP itself is less likely, but reactions to antiseptics, local anaesthetic or other products used during treatment remain possible.
Alternatives: no treatment and other skin or hair treatments depending on the indication.
Important: Blood disorders, medication, active infection and other medical factors may make PRP unsuitable or require deferral. The practitioner must review these before treatment and confirm consent.
I have read and understood the PRP information and wish to proceed to a clinician-led consent discussion
4F. Conventional microneedling This section appears because you selected conventional microneedling.
Planned microneedling area(s) Conventional microneedling consent (Required)
What the treatment is: Microneedling creates controlled micro-injuries with sterile needles to stimulate a wound-healing response. Results vary, may take time to develop and may require a course of treatment. Improvement is not guaranteed.
Expected / common effects: redness, warmth, tightness, tenderness, swelling, pinpoint bleeding, dryness/flaking and temporary sensitivity.
Important risks: bruising, infection, acne or cold-sore flare, prolonged redness, temporary or permanent hyperpigmentation or hypopigmentation, track/pattern marks, allergic/irritant reaction to products used with treatment, and scarring. Risk can be influenced by skin type, treatment depth, recent sun exposure and medical history.
Alternatives: no treatment, topical skin care, chemical peels, laser/energy treatments or other scar/skin procedures depending on the indication.
Important: Your practitioner must confirm that the planned depth, device, products and aftercare are appropriate for you and obtain final consent before treatment.
I have read and understood the microneedling information and wish to proceed to a clinician-led consent discussion
4G. Radiofrequency (RF) microneedling This section appears because you selected RF microneedling.
Planned RF microneedling area(s) Do you have any implanted electronic device, metal implant, surgical hardware or permanent threads/filler in the proposed treatment area? (Required) This may affect whether RF treatment is appropriate. Give details in the medical-details box.
RF microneedling consent (Required)
What the treatment is: RF microneedling combines needle penetration with radiofrequency energy to create controlled mechanical and thermal injury. Settings and needle depth are selected for the indication, treatment area and skin type. Results vary and are not guaranteed.
Expected / common effects: pain or heat, redness, swelling, pinpoint bleeding, tenderness, dryness/crusting and temporary sensitivity.
Important risks: bruising, infection, acne or herpes flare, prolonged redness, hyperpigmentation or hypopigmentation, burns, blistering, track marks, scarring and delayed healing. Unintended thermal injury can cause contour change or loss of subcutaneous fat; nerve irritation, altered sensation or weakness can occur rarely depending on site and depth.
Device-related considerations: implanted electrical devices, metal, threads and other implants may alter suitability. The practitioner must follow the current manufacturer instructions for the exact device.
Alternatives: no treatment, conventional microneedling, skin care, laser, HIFU or other procedures depending on your goals.
Important: Final device settings, suitability and consent must be confirmed by the treating practitioner.
I have read and understood the RF microneedling information and wish to proceed to a clinician-led consent discussion
4H. Chemical peel This section appears because you selected a chemical peel.
Planned peel depth (Required) This form does not cover deep phenol peels or surgical resurfacing.
Select peel depth Superficial peel Medium-depth peel Not yet decided / practitioner to confirm
Chemical peel consent (Required)
What the treatment is: A chemical peel applies a chemical agent to produce a controlled injury of the skin. The depth and downtime depend on the agent, concentration, contact time, skin preparation and individual response. This form covers superficial and medium-depth aesthetic peels; it does not cover deep phenol peels.
Expected / common effects: stinging/burning during application, redness, tightness, dryness, peeling/flaking, swelling, temporary darkening or bronzing and sensitivity.
Important risks: prolonged redness, blistering or crusting, infection, cold-sore reactivation, acne flare, allergic/irritant reaction, demarcation lines, temporary or permanent hyperpigmentation or hypopigmentation, delayed healing and scarring. Eye exposure can cause injury, so appropriate eye protection and careful application are required where relevant. Deeper peels generally involve more downtime and greater risk.
Alternatives: no treatment, topical skin care, microneedling, laser/energy treatment or other skin procedures depending on the indication.
Important: The practitioner must assess your skin type, pigmentation risk, medicines, recent sun exposure and exact peel product before confirming treatment and final consent.
I have read and understood the chemical peel information and wish to proceed to a clinician-led consent discussion
4I. High-intensity focused ultrasound (HIFU) This section appears because you selected HIFU.
Planned HIFU area(s) HIFU consent (Required)
What the treatment is: HIFU delivers focused ultrasound energy at selected tissue depths to create controlled thermal zones. Treatment plans and cartridges/settings vary by device and area. Results develop gradually, vary between people and are not guaranteed.
Expected / common effects: discomfort, tingling, tenderness, redness, swelling, bruising and temporary altered sensation.
Important risks: welts, burns, prolonged pain, numbness or tingling, temporary nerve irritation or muscle weakness, asymmetry, pigment change, scarring and unintended reduction in subcutaneous fat/volume or contour change. Rare or device-specific risks must be discussed based on the area and machine being used.
Alternatives: no treatment, skin care, injectables, RF, laser or surgical options depending on your goals.
Important: The practitioner must confirm treatment depth/area, device-specific contraindications and final consent before treatment.
I have read and understood the HIFU information and wish to proceed to a clinician-led consent discussion
4J. Fractional CO2 laser This section appears because you selected fractional CO2 laser.
Planned fractional CO2 area(s) Fractional CO2 laser consent (Required)
What the treatment is: Fractional CO2 laser creates columns of controlled ablative/thermal injury in the skin. The intensity, passes and coverage determine downtime and risk. This consent is for fractional CO2 resurfacing; it does not cover extensive fully ablative resurfacing.
Expected / common effects: significant redness, heat/burning sensation, swelling, pinpoint bleeding or oozing, crusting, bronzing/peeling, tightness and several days of downtime. Redness can persist longer depending on treatment intensity.
Important risks: infection (including bacterial, fungal or herpes infection), acne/milia flare, prolonged redness, delayed healing, hyperpigmentation or hypopigmentation, demarcation lines, scarring and textural change. Laser exposure can injure the eye; appropriate wavelength-specific eye protection is essential. Periocular treatment may have additional eye/eyelid risks that must be discussed by the practitioner.
Risk modifiers: darker skin types, recent tanning, pigment disorders, infection, certain medicines and aggressive settings may increase complications.
Alternatives: no treatment, topical skin care, microneedling, RF microneedling, non-ablative laser or other resurfacing options depending on your goals.
Important: Device settings, eye protection, skin preparation, aftercare and final consent must be confirmed before treatment.
I have read and understood the fractional CO2 laser information and wish to proceed to a clinician-led consent discussion
4K. Thulium laser This section appears because you selected Thulium laser.
Planned Thulium laser area(s) Thulium laser consent (Required)
What the treatment is: Thulium laser treatment uses a thulium wavelength/device to deliver controlled laser energy for selected skin indications. Exact wavelength, device, delivery mode and settings must be documented because risk and recovery vary between systems.
Expected / common effects: heat or stinging, redness, swelling, dryness, bronzing, flaking/peeling and temporary sensitivity.
Important risks: burns, blistering, infection, herpes reactivation, acne flare, prolonged redness, hyperpigmentation or hypopigmentation, demarcation, delayed healing and scarring. Laser exposure can injure the eye; suitable wavelength-specific eye protection is essential.
Alternatives: no treatment, skin care, chemical peels, microneedling or other laser/energy options depending on the indication.
Important: The practitioner must identify the exact Thulium device and indication, follow current manufacturer instructions, assess pigmentation/sun exposure/medicines and confirm final consent before treatment.
I have read and understood the Thulium laser information and wish to proceed to a clinician-led consent discussion
4L. Sclerotherapy / microsclerotherapy This section appears because you selected sclerotherapy.
Planned sclerotherapy type (Required) The exact sclerosant, concentration and method must be documented.
Select type Microsclerotherapy / liquid sclerosant for thread/spider veins Foam sclerotherapy Not yet decided / clinician to confirm
Have you ever had a DVT, pulmonary embolism, superficial thrombophlebitis, significant arterial disease or a known clotting disorder? (Required) Do you have migraine with aura or a known patent foramen ovale (PFO) / heart shunt? (Required) This is particularly relevant if foam sclerotherapy is being considered.
Sclerotherapy consent (Required)
What the treatment is: Sclerotherapy injects a sclerosant into selected veins to damage the vein lining so the vessel closes and is gradually reabsorbed. Liquid microsclerotherapy and foam techniques differ; the practitioner must confirm which is planned. More than one session may be required and veins can recur or new veins can appear.
Expected / common effects: stinging, redness, bruising, swelling, tender or firm treated veins, local inflammation/thrombophlebitis and brown pigmentation. Pigmentation usually fades but can persist. Fine new vessels ('matting') can develop.
Important risks: blistering, skin ulceration/necrosis and scarring if sclerosant leaks outside the vein or affects an unintended vessel; allergic reaction including rare severe reaction; superficial thrombosis; and deep-vein thrombosis (DVT), which can rarely lead to pulmonary embolism. With foam treatment, transient headache, migraine, chest symptoms or visual disturbance can occur; serious neurological events are very rare but have been reported.
Alternatives: no treatment, compression/conservative management, vascular assessment, laser or other vein treatments depending on the type of vein and clinical indication.
Important: Suitability depends on vein diagnosis, clotting history, mobility, pregnancy status, medicines and whether liquid or foam is used. The practitioner must confirm the indication, sclerosant and final consent before injection.
I have read and understood the sclerotherapy information and wish to proceed to a clinician-led consent discussion
4M. Hyaluronidase / filler dissolving This section appears because you selected filler dissolving.
Reason for dissolving (Required) Hyaluronidase / filler-dissolving consent (Required)
What the treatment is: Hyaluronidase is an enzyme medicine that can break down hyaluronic acid. In aesthetic practice it may be used to dissolve hyaluronic-acid dermal filler. Use for filler dissolution is outside the medicine's licensed indication, so the prescriber must explain why it is being recommended and the available alternatives.
Expected / common effects: injection discomfort, redness, swelling, bruising, tenderness and temporary unevenness. Dissolution can be incomplete or greater than intended, and repeat treatment may be needed. Appearance can change as filler is removed and normal tissue hyaluronic acid is temporarily affected.
Important risks: local inflammatory or allergic reaction and, rarely, severe allergy/anaphylaxis. Infection, bruising and tissue irritation are possible. Outcome is less predictable when the original filler type, location or amount is uncertain.
Emergency use: When vascular occlusion from hyaluronic-acid filler is suspected, urgent treatment may be recommended because delay can increase the risk of tissue loss and other serious harm. Emergency management may need to begin before every detail of an elective consultation can be completed, while still explaining the situation and seeking valid consent as far as circumstances allow.
Alternatives: observation, staged correction, referral or other complication-management options depending on the problem.
Important: The prescriber must assess allergy history, the original filler, urgency, risks and alternatives and confirm final consent before administration where circumstances allow.
I have read and understood the hyaluronidase information and wish to proceed to a clinician-led consent discussion
4N. Assessment / management of an aesthetic complication This section appears because you selected complication management.
Current concern(s) Complication-assessment acknowledgement (Required)
The clinician may need to examine you urgently, obtain information about the original treatment/product, contact the original practitioner, arrange imaging or specialist referral, prescribe/administer medicines, recommend hyaluronidase where appropriate, or advise hospital assessment. The plan depends on the diagnosis and urgency.
Where an intervention is proposed, its purpose, material risks, reasonable alternatives and consequences of not treating will be discussed and separate/final consent obtained as circumstances permit. In a true emergency, care should not be delayed by completion of this online form.
I understand that this form is for assessment and does not delay emergency care or replace consent for any procedure that may be required
5. Clinical photographs and optional secondary use Clinical photographs and marketing/education uses are separated so you can make independent choices.
May Esti-Med take clinical photographs for your confidential medical record and treatment planning? (Required) If you say No, the practitioner will discuss whether treatment can safely and appropriately proceed without clinical images.
Optional marketing / social media image consent
Optional: This permission is not required to receive treatment and declining will not affect your care. Before any identifiable image is published, the clinic should confirm the images and intended channels with you. You may withdraw permission for future uses controlled by Esti-Med by contacting the clinic. Withdrawal cannot always retrieve copies already published, downloaded, shared or cached by others.
I give permission for agreed photographs or video to be used for Esti-Med marketing and social media
Optional education / professional training image consent
Optional: This permission is separate from clinical-record photography and marketing. Images should be anonymised where practicable. If you may be identifiable, the practitioner should explain the intended audience and use before disclosure. You may withdraw permission for future uses controlled by Esti-Med.
I give permission for agreed photographs or video to be used for professional education or training
6. Privacy information Health information is special-category personal data and must be handled securely.
Privacy information acknowledgement (Required) How your information is used
Esti-Med Medical Group uses the personal, contact and health information you provide to assess your suitability for treatment, deliver and document your care, manage appointments and follow-up, and meet our professional, legal and clinical responsibilities.
Your information forms part of your confidential clinical record. We handle this information in accordance with applicable UK data protection legislation.
You can find more information about how we collect, use, store and share personal information, our lawful bases for processing, how long records are retained and your data protection rights in our Privacy Notice .
I confirm that I have been given privacy information about how my personal and health information will be used
7. Final patient declaration Please read carefully before submitting.
Patient declaration (Required)
I understand that:
I must tell the practitioner if anything changes before your procedure.
Submitting this form does not confirm suitability, guarantee a result or oblige me to proceed.
The treating practitioner must discuss the proposed treatment or procedure with me, including expected benefits, uncertainties, material risks that a reasonable person in my position would want to know, reasonable alternatives and the option of no treatment.
I can ask questions and can change my mind or withdraw consent before the procedure.
Some treatments may require additional product/device-specific information or consent where the exact product, medicine, indication, technique or risk profile differs from the general information in this form.
If treatment does not take place immediately after consent, the practitioner should check whether anything has changed and reconfirm my decision before your procedure.
I confirm that the information I have provided is accurate to the best of my knowledge
Signature (Required) Questions or concerns for the practitioner Use this space for anything you want discussed before you decide whether to proceed.